Delivery Order SPE2DB22D3011-SPE2DB25FQ0PC
- Not listed
- The Defense Logistics Agency awarded a $59,150 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a tactical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $48,881.85 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors under a firm fixed-price contract type. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. SKYRIZI is a...
- The Defense Logistics Agency awarded a $16,496.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of June 18, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $25,899.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. SKYRIZI is a biologic immunosuppressant used to...
- The Defense Logistics Agency awarded a delivery order valued at $15,904.96 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors. This firm fixed price, non-competitive delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. SKYRIZI is a prescription biologic medication used to treat...
- The Defense Logistics Agency awarded a $127,949.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors, with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $14,917.68 delivery order (Contract No. 4569133354) to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance is scheduled to be completed by August 19, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $38,911.60 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed price, non-set-aside contract will be completed by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $47,987.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this delivery order represents a specific...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ0PCDelivery Order
The Defense Logistics Agency awarded a $27,869.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors. This competitive award, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this delivery order fulfills federal medical supply requirements for military and defense healthcare systems. The award carries no set-aside designation and was processed under firm fixed-price terms, reflecting standardized pharmaceutical procurement practices. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated consistent capability in meeting federal procurement requirements through open competition. The company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard through its flexible and extensive contract vehicles supporting the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 4/25/25 |